NASDAQ: NOVT
Novanta Inc Stock

$155.66+0.36 (+0.23%)
Updated Jun 22, 2026
NOVT Price
$155.66
Fair Value Price
$32.46
Market Cap
$5.54B
52 Week Low
$98.27
52 Week High
$171.85
P/E
111.19x
P/B
4.23x
P/S
4.71x
PEG
0.85x
Dividend Yield
N/A
Revenue
$1.00B
Earnings
$53.72M
Gross Margin
44.2%
Operating Margin
8.68%
Profit Margin
5.3%
Debt to Equity
0.37
Operating Cash Flow
$84M
Beta
1.49
Next Earnings
Aug 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A

NOVT Overview

Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NOVT's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Scientific & Technical Instrument

Industry Rating
A
NOVT
Ranked
#9 of 20

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$93.23A
$373.34B
$49.23B
View Top Scientific & Technical Instrument Stocks

Be the first to know about important NOVT news, forecast changes, insider trades & much more!

NOVT News

Overview

Due Diligence Score

Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NOVT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NOVT ($155.66) is overvalued by 379.58% relative to our estimate of its Fair Value price of $32.46 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
NOVT ($155.66) is not significantly undervalued (379.58%) relative to our estimate of its Fair Value price of $32.46 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NOVT ($155.66) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NOVT due diligence checks available for Premium users.

Valuation

NOVT fair value

Fair Value of NOVT stock based on Discounted Cash Flow (DCF)

Price
$155.66
Fair Value
$32.46
Overvalued by
379.58%
NOVT ($155.66) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NOVT ($155.66) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NOVT ($155.66) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NOVT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
111.19x
Industry
87.73x
Market
7.94x
NOVT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NOVT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

NOVT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.23x
Industry
5.21x
NOVT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NOVT price to earnings growth (PEG)

For valuing profitable companies with growth potential

NOVT is good value based... subscribe to Premium to read more.
PEG Value Valuation

NOVT's financial health

Profit margin

Revenue
$257.7M
Net Income
$21.1M
Profit Margin
8.2%
NOVT's Earnings (EBIT) of $87.25M... subscribe to Premium to read more.
Interest Coverage Financials
NOVT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.8B
Liabilities
$488.0M
Debt to equity
0.37
NOVT's short-term assets ($786.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NOVT's short-term assets ($786.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NOVT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NOVT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$51.6M
Investing
-$3.8M
Financing
-$40.1M
NOVT's operating cash flow ($83.98M)... subscribe to Premium to read more.
Debt Coverage Financials

NOVT vs Scientific & Technical Instrument Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NOVTC$5.54B+0.23%111.19x4.23x
VNTC$4.26B+1.84%10.69x3.39x
BMID$3.93B-0.50%30.23x5.70x
ITRIC$3.63B+1.18%12.84x2.26x
STB$7.52B+2.11%161.56x2.63x

Novanta Stock FAQ

What is Novanta's quote symbol?

(NASDAQ: NOVT) Novanta trades on the NASDAQ under the ticker symbol NOVT. Novanta stock quotes can also be displayed as NASDAQ: NOVT.

If you're new to stock investing, here's how to buy Novanta stock.

What is the 52 week high and low for Novanta (NASDAQ: NOVT)?

(NASDAQ: NOVT) Novanta's 52-week high was $171.85, and its 52-week low was $98.27. It is currently -9.42% from its 52-week high and 58.4% from its 52-week low.

How much is Novanta stock worth today?

(NASDAQ: NOVT) Novanta currently has 35,611,858 outstanding shares. With Novanta stock trading at $155.66 per share, the total value of Novanta stock (market capitalization) is $5.54B.

Novanta stock was originally listed at a price of $51.75 in Dec 31, 1997. If you had invested in Novanta stock at $51.75, your return over the last 28 years would have been 200.79%, for an annualized return of 4.01% (not including any dividends or dividend reinvestments).

How much is Novanta's stock price per share?

(NASDAQ: NOVT) Novanta stock price per share is $155.66 today (as of Jun 22, 2026).

What is Novanta's Market Cap?

(NASDAQ: NOVT) Novanta's market cap is $5.54B, as of Jun 23, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novanta's market cap is calculated by multiplying NOVT's current stock price of $155.66 by NOVT's total outstanding shares of 35,611,858.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.